Clinical Trial Update: Budesonide Treatment for Lymphocytic Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating budesonide for microscopic colitis (lymphocytic colitis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Colitis
• Microscopic Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Microscopic Colitis | Phase 3 | Status: COMPLETED